Skip to main content
SpringerLink
Log in

Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease

  • Book
  • © 2003
  • Latest edition

Overview

Editors:
  1. A. Michael Lincoff

    1. Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Contemporary Cardiology (CONCARD)

  • 2295 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (21 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Basic Principles

    1. Front Matter

      Pages 1-1
      Download chapter PDF

    2. Thrombosis in Acute Coronary Syndromes and Coronary Interventions

      • Thaddeus R. Tolleson, Robert A. Harrington
      Pages 3-21

    3. Platelet Adhesion

      • Edward E. Plow
      Pages 23-37

    4. Glycoprotein IIb/IIIa in Platelet Aggregation and Acute Arterial Thrombosis

      • Patrick Andre, David R. Phillips
      Pages 39-71

    5. Glycoprotein IIb/IIIa Antagonists

      • Barry S. Coller
      Pages 73-101

  3. Glycoprotein IIb/IIIa Blockade During Coronary Intervention

    1. Front Matter

      Pages 103-103
      Download chapter PDF

    2. Abciximab During Percutaneous Coronary Intervention

      • A. Michael Lincoff
      Pages 105-124

    3. Eptifibatide in Coronary Intervention

      • Jean-Pierre Deg, J. Conor O’Shea, James E. Tcheng
      Pages 125-146

    4. Tirofiban in Interventional Cardiology

      • Nicholas Valettas, Howard C. Herrmann
      Pages 147-166

    5. Overview of the Glycoprotein IIb/IIIa Interventional Trials

      • A. Michael Lincoff, Eric J. Topol
      Pages 167-199

  4. Glycoprotein IIB/IIIA Blockade for Acute Ischemic Syndromes

    1. Front Matter

      Pages 201-201
      Download chapter PDF

    2. The Use of Abciximab in Therapy-Resistant Unstable Angina

      • Marcel J. B. M. van den Brand, Maarten L. Simoons
      Pages 203-231

    3. Unstable Angina Trials

      • David J. Moliterno
      Pages 233-262

    4. Platelet Glycoprotein IIb/IIIa Inhibitors and an Invasive Strategy

      • Christopher P. Cannon
      Pages 263-273

    5. Glycoprotein IIb/IIIa Receptor Blockade in Myocardial Infarction

      • Franz-Josef Neumann
      Pages 275-287

    6. Glycoprotein IIb/IIIa Receptor Blockade in Acute Myocardial Infarction

      • Sorin J. Brener
      Pages 289-302

  5. Practical Issues and Future Applications

    1. Front Matter

      Pages 303-303
      Download chapter PDF

    2. Economics of Glycoprotein IIb/IIIa Inhibition

      • Daniel B. Mark
      Pages 305-319

    3. Platelet Monitoring and Interaction of Glycoprotein IIb/IIIa Antagonists with Other Antiplatelet Agents

      • Steven R. Steinhubl
      Pages 321-340
Back to top

Keywords

About this book

A. Michael Lincoff takes advantage of critically important new knowledge arising from recent clinical trials to update and expand his acclaimed Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease. This substantially enhanced Second Edition contains new chapters on the role of GPIIb/IIIa blockade during acute coronary syndromes, on outcomes with chronic oral GPIIb/IIIa blockade following acute coronary syndromes, and on fibrinolytic therapy during acute myocardial infarctions. Additional enhancements include revised findings from the latest trials of GPIIb/IIIa inhibition during percutaneous coronary intervention, discussion of GPIIb/IIIa blockade with other platelet and thrombin inhibitors, and a review of the potential effects beyond inhibition of platelet aggregation. The book also explains the scientific basis of this therapy, evaluates its benefits and risks for patients, and summarizes detailed data from its various clinical trials.
Comprehensive and definitive, Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease, Second Edition offers physicians, cardiologists, emergency room doctors, and basic scientists a complete and authoritative review of the state-of-the-art in glycoprotein IIb/IIIa receptor inhibitor use today.

Reviews

"...provides the reader with extensive and profound information about this new class, based on data from completed and ongoing trials...can be recommended not only to cardiologists but to all clinicians and researchers interested in this field."
-Intensive Care Medicine

Editors and Affiliations

  • Department of Cardiovascular Medicine, The Cleveland Clinic Foundation, Cleveland, USA

    A. Michael Lincoff

Bibliographic Information

  • Book Title: Platelet Glycoprotein IIb/IIIa Inhibitors in Cardiovascular Disease

  • Editors: A. Michael Lincoff

  • Series Title: Contemporary Cardiology

  • DOI: https://doi.org/10.1007/978-1-59259-376-7

  • Publisher: Humana Totowa, NJ

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer Science+Business Media New York 2003

  • Hardcover ISBN: 978-1-58829-185-1Published: 07 March 2003

  • Softcover ISBN: 978-1-61737-408-1Published: 09 November 2010

  • eBook ISBN: 978-1-59259-376-7Published: 07 March 2003

  • Series ISSN: 2196-8969

  • Series E-ISSN: 2196-8977

  • Edition Number: 2

  • Number of Pages: X, 476

  • Topics: Cardiology

Publish with us

Policies and ethics

Back to top

Search

Navigation